C12N 2710/00041
Use of virus, viral particle or viral elements as a vector
C12N2710/00041 (Use of virus, viral particle or viral elements as a vector) appears on 31 US grants and 53 published applications in this corpus.
Search patents in C12N- Granted patents
- 31
- Published applications
- 53
- Assignees
- 26
- Inventors
- 82
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 2 | 2 |
| 2006 | 2 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 2 |
| 2015 | 2 | 3 |
| 2016 | 3 | 8 |
| 2017 | 2 | 0 |
| 2018 | 3 | 5 |
| 2019 | 2 | 5 |
| 2020 | 3 | 3 |
| 2021 | 0 | 3 |
| 2022 | 6 | 4 |
| 2023 | 1 | 4 |
| 2024 | 0 | 3 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/00043Viral genome or elements thereof as genetic vectorIndexing code21
- C12N 2710/00045Special targeting system for viral vectorsIndexing code4
- C12N 2710/00042Virus or viral particle as vehicleIndexing code3
- C12N 2710/00044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
Recent patents
- Crispr-CAS10 systems and methods for phage genome editing5 Aug 2025US 12,378,577 B2The Board of Trustees of The University of Alabama
- Methods and compositions for attenuating anti-viral transfer vector immune responses25 Apr 2023US 11,633,422 B2Selecta Biosciences, Inc.
- Oncolytic adenoviruses coding for bi-specific antibodies1 Nov 2022US 11,485,791 B2Tilt Biotherapeutics Oy
- Crispr-CAS10 systems and methods for phage genome editing27 Sep 2022US 11,453,892 B2The Board of Trustees of The University of Alabama
- Compact gyroplane employing torque compensated main rotor and hybrid power train6 Sep 2022US 11,433,093 B2
- Killer yeasts to prevent spoilage of beer6 Aug 2026US 2026/0226380 A1University of Idaho
- Construction method of bacterial cellulose (bc)-enriched plant using multi-gene tandem and use thereof9 Oct 2025US 2025/0313850 A1Shanghai Academy of Agricultural Sciences
- Compositions and Methods for Gene Delivery to the Airways and/or Lungs20 Feb 2025US 2025/0059565 A1Krystal Biotech, Inc.
- Sequences and promoters for use in plant cells and methods of making and using such sequences24 Oct 2024US 2024/0352473 A1Futuragene Israel Ltd.
- Recombinant Ranavirus, Methods of Production, and Its Use As A Mammalian Expression System15 Feb 2024US 2024/0050549 A1The Trustees of the California State University
Most cited
By later US patents
- Plant expression constructs1,417US 6,660,911 B2Monsanto Technology LLC · 2003
- Chimeric figwort mosaic virus-elongation factor 1 α promoters and methods of using them1,389US 6,949,696 B2Monsanto Technology LLC · 2005
- Glyphosate resistant plants using hybrid promoter constructs1,380US 7,141,722 B2Monsanto Technology LLC · 2006
- Plants having high plant map values130US 7,112,725 B2Monsanto Technology LLC · 2006
- Plant expression constructs53US 6,462,258 B1Monsanto Technology LLC · 2002